W STRATEGIES, LLC

Lobbying for ABBVIE INC. · Biopharmaceutical company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · $50,000.00 income · posted Apr 18, 2025

Lobbying activity 2

Health Issues

Education and legislation related to reform of the 340(b) program.

Medicare/Medicaid

Medicare Implementation of the Inflation Reduction Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.